Cantor Fitzgerald Initiates Coverage On Atrium Therapeutics with Overweight Rating, Announces Price Target of $25
Atrium Therapeutics Inc RNA
$12.66
▲ +1.44%
(+$0.18)
Open
$12.83
Prev Close
$12.48
Day Range
$12.20 – $12.96
52W Range
$11.40 – $73.06
Market Cap
$216.56M
Beta
1.01
EPS (TTM)
$-3.86
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2026-02-27 |
| Shares Out. | 17,110,000 |
| Phone | 13026587581 |
Atrium Therapeutics Inc is a publicly traded company under the ticker symbol RNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
5 analysts (2026-06-01)